A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

NCT02951364 ·Status: COMPLETED

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01026610 ·Status: COMPLETED ·Phase: PHASE2

HEPSERA Post Marketing Surveillance

NCT01329419 ·Status: COMPLETED

Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants

NCT02166047 ·Status: COMPLETED ·Phase: PHASE2

A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

NCT00641082 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

NCT02979613 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated

NCT02579382 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

NCT05957380 ·Status: COMPLETED ·Phase: PHASE4

Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

NCT00305019 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

NCT02981602 ·Status: COMPLETED ·Phase: PHASE2

A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

NCT06311734 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

NCT06263959 ·Status: RECRUITING ·Phase: PHASE2

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

NCT01958229 ·Status: COMPLETED

Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group

NCT00313261 ·Status: TERMINATED ·Phase: PHASE2

Study of Telbivudine in Chronic Hepatitis B

NCT00970216 ·Status: COMPLETED

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01242787 ·Status: UNKNOWN ·Phase: PHASE2

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996 ·Status: COMPLETED ·Phase: PHASE2

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

NCT00625560 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine

NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-term Study With Clevudine

NCT00558818 ·Status: COMPLETED ·Phase: PHASE4

Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

NCT00362674 ·Status: COMPLETED

A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B

NCT03426618 ·Status: COMPLETED

Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea

NCT01776814 ·Status: UNKNOWN

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

NCT01300234 ·Status: COMPLETED ·Phase: PHASE3